Victor Perlroth Buys 300,000 Kodiak Shares, Boosting Confidence Ahead of FDA Zenkuda Submission
CEO Victor Perlroth’s $1.04 buy of 300k Kodiak Sciences shares underscores strong insider confidence amid soaring Phase III results and a looming FDA Zenkuda submission.
4 minutes to read